TraderTV Live was happy to welcome Filament Health Corp. CEO Ben Lightburn to the show, Filament is an exclusively-natural psychedelic drug discovery and extraction technology company, the firm recently received its final approval to list its common shares on the Neo Exchange Inc. and began trading June 24, 2021 under the symbol NEO: FH.********* Watch our Live Trading show, Monday to Friday from 8:30 am to 11:30am!
Legal Notice: The views and opinions expressed on TraderTV.Live are provided for information purposes only and should NOT be taken as (a) a solicitation of an offer to buy or sell a security, (b) an endorsement or recommendation of any particular security or trading strategy, or (c) investment advice.
The trading activity shown on TraderTV.Live are stocks, futures and Forex purchases and sales, using real money and real-time market data. Our traders may own the securities they are trading on TraderTV.Live in their personal portfolios.
BEFORE MAKING ANY INVESTMENT DECISION, IT IS STRONGLY RECOMMENDED YOU SEEK ADVICE FROM A QUALIFIED BROKER OR INVESTMENT ADVISOR.
TRADERTV.LIVE DOES NOT PROVIDE OR GUARANTEE ANY FINANCIAL, LEGAL, TAX, OR ACCOUNTING ADVICE OR ADVICE REGARDING THE SUITABILITY, PROFITABILITY, OR POTENTIAL VALUE OF ANY PARTICULAR SECURITY, TRADING STRATEGY, OR INFORMATION SOURCE.
This segment of TraderTV.Live features an interview of a representative of a company publicly traded in the United States (the “Profiled Issuer”) discussing the company, its business, and/or its prospects (the “Information”). TraderTV.Live has not reviewed or vetted, and does not make any comment on or otherwise endorse, the accuracy, relevance, or completeness of the Information. Since we have been paid to disseminate the Information to the public pertaining to securities of the Profiled Issuer, we are required by Section 17(b) of the Securities Act of 1933, as amended, to specifically disclose our compensation. TraderTV.Live received payment of 3000 Canadian dollars from the Profiled Issuer’s media representative as consideration for the Profiled Issuer’s representative being interviewed on the show.